LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib in patients with advanced renal cell carcinoma.

被引：0

作者：

McDermott, David F.

Peer, Avivit

Agarwal, Neeraj

Atkins, Michael B.

Cornell, Jerry

Perini, Rodolfo F.

Grossmann, Kenneth F.

Gurney, Howard

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA USA

[2] Rambam Hlth Care Campus, Haifa, Israel

[3] Huntsman Canc Inst, Salt Lake City, UT USA

[4] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA

[5] Merck & Co Inc, Rahway, NJ USA

[6] Westmead Hosp, Sydney, NSW, Australia

[7] Macquarie Univ, Sydney, NSW, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS747

引用

页数：1